This is a $95,605 firm-fixed-price purchase order awarded by the Southeast Area office of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the GRIDLON X5-CAPEX genomic sequencing system and related products and services, with an ultimate completion date of October 4, 2019. The contract does not have a set-aside designation. Oxford Nanopore Technologies is a prime federal contractor that has secured numerous awards...
This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the delivery of RNA sequencing kits, ligation sequencing kits, rapid barcoding kits, and flow cells. The $70,000.00 firm-fixed-price purchase order was awarded by the Southeast Area office of a civilian federal agency. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts to provide...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of nanopore flow-cells and a ligation kit. The $19,227.99 firm fixed-price purchase order was awarded by the Northeast Area division of the U.S. Department of Agriculture's Agricultural Research Service. The contract has an ultimate completion date of May 10, 2024. Oxford Nanopore has secured multiple federal contracts and Indefinite Delivery Vehicles (IDVs)...
This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not...
This firm-fixed-price purchase order was awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $15,040 contract is for the provision of Oxford Nanopore's proprietary library preparation kits and flow cells for long-read DNA/RNA sequencing to support ongoing NIDCD research projects. This award...
This is a $22,986 firm-fixed-price purchase order awarded by the Defense Health Agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for specialized reagents and equipment for next-generation long-range DNA and RNA sequencing. This purchase order is part of a larger $325,000 Blanket Purchase Agreement held by Oxford Nanopore with the Defense Health Agency for reagents, equipment, warranty, and license services, valid through February...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...